BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 28383782)

  • 1. The miR-200b-ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma.
    Tsai SC; Lin CC; Shih TC; Tseng RJ; Yu MC; Lin YJ; Hsieh SY
    Mol Carcinog; 2017 Sep; 56(9):2035-2047. PubMed ID: 28383782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YB1 regulates miR-205/200b-ZEB1 axis by inhibiting microRNA maturation in hepatocellular carcinoma.
    Liu X; Chen D; Chen H; Wang W; Liu Y; Wang Y; Duan C; Ning Z; Guo X; Otkur W; Liu J; Qi H; Liu X; Lin A; Xia T; Liu HX; Piao HL
    Cancer Commun (Lond); 2021 Jul; 41(7):576-595. PubMed ID: 34110104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1.
    Wu WR; Sun H; Zhang R; Yu XH; Shi XD; Zhu MS; Zeng H; Yan LX; Xu LB; Liu C
    Oncotarget; 2016 Apr; 7(14):18684-93. PubMed ID: 26919246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.
    Yamada T; Abei M; Danjoh I; Shirota R; Yamashita T; Hyodo I; Nakamura Y
    BMC Cancer; 2015 Apr; 15():260. PubMed ID: 25885470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal miR-200b-3p induce macrophage polarization by regulating transcriptional repressor ZEB1 in hepatocellular carcinoma.
    Xu Y; Luan G; Liu F; Zhang Y; Li Z; Liu Z; Yang T
    Hepatol Int; 2023 Aug; 17(4):889-903. PubMed ID: 36930410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-26b-5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC.
    Khosla R; Hemati H; Rastogi A; Ramakrishna G; Sarin SK; Trehanpati N
    Liver Int; 2019 Sep; 39(9):1692-1703. PubMed ID: 31276277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of pseudogene UPAT leads to hepatocellular carcinoma progression and forms a positive feedback loop with ZEB1.
    Xiang L; Huang X; Wang S; Ou H; Chen Z; Hu Z; Huang Y; Li X; Yuan Y; Yang D
    Cancer Sci; 2020 Nov; 111(11):4102-4117. PubMed ID: 32808348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.
    Li B; Liu D; Yang P; Li HY; Wang D
    Gene; 2019 Jul; 707():78-85. PubMed ID: 31075412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features.
    Gu Y; Wei X; Sun Y; Gao H; Zheng X; Wong LL; Jin L; Liu N; Hernandez B; Peplowska K; Zhao X; Zhan QM; Feng XH; Tang ZY; Ji J
    Cancer Res; 2019 Mar; 79(5):941-953. PubMed ID: 30530815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer.
    Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X
    J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zeb1 Regulates the Symmetric Division of Mouse Lewis Lung Carcinoma Stem Cells through Numb mediated by miR-31.
    Wang J; Zhou T; Sun Z; Ye T; Zhou S; Li J; Liu Y; Kong L; Tang J; Liu D; Xing HR
    Int J Biol Sci; 2018; 14(11):1399-1410. PubMed ID: 30262992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase 1/Sp1/microRNA-200b signaling accounts for maintenance of cancer stem-like cells in human lung adenocarcinoma.
    Chen DQ; Huang JY; Feng B; Pan BZ; De W; Wang R; Chen LB
    PLoS One; 2014; 9(10):e109578. PubMed ID: 25279705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis.
    Wong CM; Wei L; Au SL; Fan DN; Zhou Y; Tsang FH; Law CT; Lee JM; He X; Shi J; Wong CC; Ng IO
    Oncotarget; 2015 May; 6(15):13658-70. PubMed ID: 25909223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc-finger E-box-binding homeobox 1 (ZEB1) plays a crucial role in the maintenance of lung cancer stem cells resistant to gefitinib.
    Nurwidya F; Takahashi F; Winardi W; Tajima K; Mitsuishi Y; Murakami A; Kobayashi I; Nara T; Hashimoto M; Kato M; Hidayat M; Suina K; Hayakawa D; Asao T; Ko R; Shukuya T; Yae T; Shimada N; Yoshioka Y; Sasaki S; Takahashi K
    Thorac Cancer; 2021 May; 12(10):1536-1548. PubMed ID: 33764690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma.
    Yang YM; Lee WH; Lee CG; An J; Kim ES; Kim SH; Lee SK; Lee CH; Dhanasekaran DN; Moon A; Hwang S; Lee SJ; Park JW; Kim KM; Kim SG
    Oncogene; 2015 May; 34(22):2910-21. PubMed ID: 25065598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.